CIC 2Q FY26 Earnings Review - BRS Equity Research
Earnings Reviews
26/11/2025
632
0
π Solid fundamentals leaves room for re-rating π° 2Q FY26 PATMI of LKR 1.4bn (+29% YoY) with EPS of LKR 0.73, driven by strong performance from crop solutions and livestock solutions during the quarter.πΎ Strong Agri Cluster Performance: Supported by consumer spending power and uptick in tourist arrivals.π Livestock: Favourable market conditions for feed and poultry. π Industrial Activity to pickup: Seasonal demand anticipated for packaging while revival of export industries and construction activities in 2H FY26E to drive demand for industrial chemicals. π Margins: Specialized fertilizer, herbal healthcare and novel therapy pharma molecules to drive margins. βοΈ Export potential: Seeds, Herbal Healthcare (Link Natural) and Health Rice varieties. π Valuation & recommendation: Target prices revised to LKR 40 (CIC.N β BUY) and LKR 32 (CIC.X β BUY) for FY27E. β Risks: Erratic weather, regulatory changes, exchange rate fluctuations, rising global fertilizer prices
You must login to post a comment.